Shanghai Haoyuan Chemexpress (688131.SH) has received approval from the China Securities Regulatory Commission to issue convertible bonds.
Hao Yuan Pharmaceuticals (688131.SH) announced that the company received a notice from the China Securities Regulatory Commission on September 21, 2024...
Shanghai Haoyuan Chemexpress (688131.SH) announced that on September 21, 2024, the company received approval from the China Securities Regulatory Commission for the registration of the issuance of convertible bonds to unspecified investors. The approval allows the company to proceed with the application to issue convertible bonds to unspecified investors.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


